HAO Stock Crashes 93.84% on May 12, 2026 as NASDAQ Penny Stock Plummets

Haoxi Health Technology Limited (NASDAQ: HAO) experienced a catastrophic intraday collapse on May 12, 2026, with HAO stock plummeting 93.84% to just $0.0411 USD. The Beijing-based online marketing company, which went public in January 2024, saw its share price evaporate from a previous close of $0.73. Despite the dramatic decline, the company announced a $6.5 million registered direct offering to shore up its balance sheet. Trading volume surged to 343.9 million shares, making HAO one of the most actively traded penny stocks on NASDAQ today. The collapse marks an extraordinary reversal for the healthcare advertising specialist.

What Triggered HAO Stock’s Historic Collapse Today

HAO stock’s devastating 93.84% single-day crash represents one of the most severe intraday declines in recent NASDAQ history. The stock fell from $0.73 to $0.0411, wiping out nearly all shareholder value in hours. Trading activity exploded to 343.9 million shares, dwarfing the typical daily volume of 22,810 shares. This represents a relative volume spike of 9,390x normal levels, indicating panic selling and forced liquidations across the board.

The timing coincides with Haoxi’s announcement of a $6.5 million direct offering at $0.25 per share. This capital raise, while necessary for operations, signals severe financial distress. The company issued 9 million Class A shares and 17 million pre-funded warrants, heavily diluting existing shareholders. Market sentiment turned sharply negative as investors realized the offering price was far below current trading levels.

HAO Stock’s Technical Breakdown and Market Sentiment

Technical indicators paint an extremely bearish picture for HAO stock. The Relative Strength Index (RSI) sits at 14.08, deep in oversold territory below 30. The Commodity Channel Index (CCI) reads -226.50, indicating extreme selling pressure. Williams %R stands at -99.59, suggesting maximum downward momentum. These readings suggest capitulation selling has reached extreme levels.

Trading Activity: Volume exploded to 343.9 million shares as investors rushed for exits. The Money Flow Index (MFI) dropped to just 1.68, reflecting severe liquidation. Liquidation: The Average True Range (ATR) expanded to 0.17, showing massive price swings. The MACD histogram turned deeply negative at -0.07, confirming downward momentum. Track HAO on Meyka for real-time updates on this volatile penny stock.

Haoxi’s Financial Position and Year-to-Date Performance

HAO stock has suffered catastrophic losses across all timeframes. Year-to-date, the stock is down 95.79%, while the one-year decline reaches 97.22%. The three-year loss stands at 99.97%, meaning early investors have lost virtually everything. The stock’s 52-week range spans from $0.0403 (low) to $2.31 (high), showing extreme volatility and deterioration.

Meyka AI rates HAO with a grade of B-, suggesting a neutral stance despite the collapse. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company’s market capitalization has shrunk to just $337,636 USD, making it a micro-cap penny stock. These grades are not guaranteed and we are not financial advisors. The company’s balance sheet shows a current ratio of 3.45x, indicating adequate short-term liquidity despite operational challenges.

Haoxi’s Business Model and Market Position

Haoxi Health Technology operates as an online marketing solutions provider focused on China’s healthcare advertising sector. The company specializes in short-video marketing across platforms like Douyin, Toutiao, WeChat, and Sina Weibo. Founded in 2018 and headquartered in Beijing, Haoxi employs just 30 full-time staff members. Revenue per share reached $9.51 TTM, but the company reported negative net income of -$0.62 per share.

The company’s profitability metrics are deeply negative. Operating profit margin stands at -17.69%, while net profit margin is -6.50%. Return on equity (ROE) is -16.63%, and return on assets (ROA) is -13.42%. These metrics indicate the company is burning cash and losing money on operations. The price-to-sales ratio of 0.0073x appears cheap, but reflects the market’s lack of confidence in the business model and future prospects.

Final Thoughts

HAO stock’s 93.84% intraday collapse on May 12, 2026 represents a complete market repricing of Haoxi Health Technology Limited. The $6.5 million direct offering at $0.25 per share triggered panic selling, as existing shareholders faced severe dilution. With trading volume exploding to 343.9 million shares and technical indicators flashing extreme oversold signals, the market has effectively abandoned the stock. The company’s negative profitability, minimal market cap of $337,636, and deteriorating fundamentals suggest further downside risk. Investors should recognize HAO as a highly speculative penny stock with significant bankruptcy risk. This represents a cautionary tale about micro-cap…

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.